Potent inhibitors of phosphatidylinositol 3 (PI3) kinase that have antiproliferative activity only when delivered as prodrug forms
NJ O'Brien, S Amran, J Medan, B Cleary…
Index: O'Brien, Nathan J.; Amran, Syazwani; Medan, Jelena; Cleary, Ben; Deady, Leslie W.; Jennings, Ian G.; Thompson, Philip E.; Abbott, Belinda M. ChemMedChem, 2013 , vol. 8, # 6 p. 914 - 918
Full Text: HTML
Citation Number: 3
Abstract
Phosphatidylinositol 3 kinase (PI3K) enzymes have emerged as important therapeutic targets in recent years as PI3K isoforms are involved in numerous cell signaling pathways associated with a range of diseases.[1] Prominent among these is cancer, with numerous instances of genetic mutations that enhance the PI3K signal identified, such as mutations in the PI3KCA gene that expresses PI3Ka, and downregulation of phosphatase PTEN that ...
Related Articles:
[Chakraborti, Asit K.; Sharma, Lalima; Gulhane, Rajesh; Shivani Tetrahedron, 2003 , vol. 59, # 39 p. 7661 - 7668]
[Komiya, Sanshiro; Akai, Yasushi; Tanaka, Kohkichi; Yamamoto, Takakazu; Yamamoto, Akio Organometallics, 1985 , vol. 4, p. 1130 - 1136]
Conversion of N-Aromatic Amides to O-Aromatic Esters
[Glatzhofer, Daniel T.; Roy, Raymond R.; Cossey, Kimberly N. Organic Letters, 2002 , vol. 4, # 14 p. 2349 - 2352]
[Stefanidis, Dimitrios; Cho, Sayeon; Dhe-Paganon, Sirano; Jencks, William P. Journal of the American Chemical Society, 1993 , vol. 115, # 5 p. 1650 - 1656]
[Yamamoto, Takakazu; Kohara, Teiji; Yamamoto, Akio Bulletin of the Chemical Society of Japan, 1981 , vol. 54, # 7 p. 2161 - 2168]